EON Network: November 2025 Newsletter |
The EON Network was established to facilitate communication between exercise oncology and oncology nutrition researchers and clinicians to achieve our joint goal of improving cancer treatment outcomes.
The EON Network monthly newsletter includes upcoming webinars, updates on exercise oncology and oncology nutrition related events, publications that may be of interest, and resources. This information is also available on the EON Network webpage. Past newsletters are archived.
|
|
|
EON Webinar Series: 2025-2026 Presenters
|
The EON Webinar Series returns this fall with an outstanding group of speakers!
As a reminder, recordings of past webinars are available on the EON Network webpage.
|
|
|
December 4, 2025 | 3:00 - 4:00 PM ET
|
|
|
| The CHALLENGE Trial was Positive: What's Next for the Field of Exercise Oncology?
In this presentation, Prof. Courneya will present the results of the groundbreaking CHALLENGE trial demonstrating that structured exercise after adjuvant chemotherapy for colon cancer improves survival. He will then discuss the implications of the first positive phase 3 exercise trial on clinical practice and future research.
|
|
|
February 26, 2026 | 3:00 - 4:00 PM ET
|
|
|
| Improving Oncology Outcomes Through Targeted Nutritional Assessment and Intervention
Cancer and its treatments substantially impact nutritional status and overall patient outcomes. Malnutrition and muscle loss are highly prevalent challenges that compromise treatment tolerance, increase toxicity, and diminish quality of life and survival. This presentation will highlight emerging evidence on the role of targeted nutrition strategies, emphasizing the importance of comprehensive assessment and individualized intervention. Drawing on data from clinical trials and translational research, the session will explore updated insights into energy and protein requirements in oncology, including how factors such as inflammation influence anabolic response. It will also underscore the importance of integrating nutrition into multidisciplinary cancer care to optimize outcomes across the continuum.
|
|
|
April 9, 2026 | 2:00 - 3:00 PM ET
|
|
|
| Coffee consumption and improved colorectal cancer survivorship: from observational to interventional studies
Observational findings from several independent cohorts have consistently shown a beneficial association of coffee consumption after diagnosis with better survival outcomes among patients with colorectal cancer. In support of these data, coffee has been linked to lower risk of metabolic disorders, lower inflammation, and favorable blood biochemical profiles. While the components in coffee that drive these benefits remain unknown, studies of metabolomics and microbiome have identified potential molecules and mechanisms of action underlying coffee's beneficial effects. These data altogether have motivated the conduct of the first randomized control trial of coffee consumption among colorectal cancer survivors (the COMMENCER trial). In this presentation, Dr. Song will review the existing data, present the COMMENCER trial, and discuss the future directions.
|
|
|
Transdisciplinary Research on Energetics and Cancer (TREC) Training Workshop 2026
|
The Transdisciplinary Research on Energetics and Cancer (TREC) Training Workshop builds upon the NCI TREC Initiative and covers topics across the cancer control and T0-T4 continua.
Now in our 10th year, this Workshop is funded by the National Cancer Institute and led by Yale University’s Dr. Melinda Irwin with expert international faculty. TREC builds collaborations among basic sciences, clinician-researchers, and population scientists in energy balance and cancer research. The program is designed for junior faculty and postdocs. This 5-day, in residence Workshop places emphasis on developing and applying transdisciplinary and translational competencies focused on energetics (obesity, diet and exercise) and cancer. Expert faculty and fellow alumni span an array of professional disciplines, from basic scientists to clinicians to behavioral and population scientists. Formal didactic learning is integrated with one-on-one dialog and small group discussions to enable fellows to learn from each other and from faculty, and to develop a TREC network.
The 10th annual course will be held June 22-26, 2026 at Water’s Edge Resort, Westbrook, CT. Costs are covered.
Notification of Intent to apply (simple, informal email to dlowry@fredhutch.org) due no later than December 20, 2025.
Full application is due no later than January 20, 2026.
For more detail and to apply, visit TRECTraining.yale.edu.
Questions: contact Diana Lowry dlowry@fredhutch.org.
|
Invitation to Submit Additional Opportunities
|
Opportunities such as training workshops, publication submissions, and funding applications are great to share with the EON Network. We invite all to submit relevant opportunities by emailing eonnetwork@bsc.gwu.edu!
|
|
|
Robien K, Wopat H. Landscape analysis of oncology nutrition research among patients being treated for cancer. Support Care Cancer 2025;33(11):957. PMID: 41102377
Marris KE, Cole RM, Addison D, Ruz P, Sparagna G, Ni A, Belury MA. The relationship between blood lipidomics and cardiotoxic injury following acute exposure to anthracycline chemotherapy in women with breast cancer: a feasibility study. Curr Dev Nutr 2025 Sep 4;9(10):107552. PMID: 41069420
Schmitz KH, Rogers LQ. Translation of Evidence to Clinical Practice for Exercise Oncology: An Update from the Moving Through Cancer Initiative. Exerc Sport Sci Rev 2025 Oct 23. Epub ahead of print. PMID: 41128469
Cao A, Fumagalli IA, Chen WY, Llanos AAM, Quesenberry CP, Caan BJ, Cespedes Feliciano EM. Association between thoracic adiposity and survival in non-metastatic breast cancer. Breast Cancer Res 2025;27(1):176. PMID: 41088394
Salehin M, Yang Chow VT, Lee H, Weltzien EK, Nguyen L, Li JM, Akella V, Caan BJ, Cespedes Feliciano EM, Ma D, Beg MF, Popuri K. Validation of automated computed tomography segmentation software to assess body composition among cancer patients. Clin Nutr ESPEN 2025;69:686-695. PMID: 40865606
|
|
|
Manage your preferences | Opt Out using TrueRemove™
Got this as a forward? Sign up to receive our future emails.
View this email online.
|
6110 Executive Blvd Suite 750 | Rockville, MD 20852 US
|
|
|
This email was sent to .
To continue receiving our emails, add us to your address book.
| |
|
|
